Health
Botanix collab with UQ confirms antimicrobial potential of CBD – Stockhead
Botanix Pharmaceuticals shares are on the rise after research showed that a synthetic cannabidiol formulation can kill so-called “superbugs”.
Link copied toclipboard
BotanixPharmaceuticals (ASX:BOT) shares are on the rise this morning after research from the University of Queensland showed that a synthetic cannabidiol formulation can kill so-called “superbugs”, or gram-negative bacteria.
CBD can destroy the bacteria responsible for gonorrhoea, meningitis and legionnaire’s disease, according to the Botanix-backed article published today in the peer-reviewed journal Communications Biology.
“Our results demonstrate that cannabidiol has excellent…
-
General19 hours agoZac Lomax released by Eels for ‘opportunities outside NRL’, fuelling speculation of R360 switch
-
Noosa News22 hours agoMore children’s sand products from Kmart and Target recalled over asbestos contamination fears
-
Noosa News23 hours agoBurgess Creek to go weed free
-
General17 hours agoIslam Makhachev claims UFC welterweight belt with dominant win over Jack Della Maddalena